VI
Vimta Labs Ltd (VIMTALABS)
₹584.35
Mkt cap
₹2,696 Cr
P/E ratio
33.40
P/B
5.73
Div yield
0.33%
ROE
18.90%
ROCE
25.20%
EPS (TTM)
₹17.50
Book value
₹102
52W range
376–775
Sector
Healthcare
Price history
Previous close
Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider [1]
NSE VIMTALABSBSE 524394
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−24.60% from high₹584
₹376+55.39% from low₹775
Current
₹584.35
Prev close
₹600.30
Day
−2.66%
Price performance
1D
−1.72%
1W
−1.26%
1M
−10.84%
3M
+0.78%
6M
+54.98%
1Y
−19.39%
YTD
−4.24%
Financials
Revenue, profit & margin
P/E ratio
33.4×
VIMTALABS is 11% below the sector median of 37.4×
VIMTALABS33.4×
Sector median37.4×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 64 | 73 | 73 | 75 | 85 | 90 | 94 | 98 | 102 | 99 | 109 | 109 | |
| Expenses | 58 | 48 | 50 | 47 | 49 | 55 | 57 | 61 | 64 | 68 | 64 | 70 | 72 | |
| Operating Profit | 24 | 17 | 23 | 26 | 26 | 30 | 33 | 33 | 34 | 34 | 34 | 39 | 37 | |
| OPM % | 29% | 26% | 31% | 36% | 35% | 35% | 37% | 35% | 35% | 34% | 35% | 36% | 34% | |
| Other Income | 1 | 0 | -1 | -1 | -1 | -1 | 5 | 2 | 2 | 3 | 0 | 3 | 4 | |
| Interest | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 8 | 9 | 8 | 8 | 8 | 8 | 10 | 9 | 10 | 10 | 11 | 13 | 13 | |
| Profit before tax | 16 | 8 | 13 | 16 | 17 | 20 | 28 | 25 | 25 | 26 | 23 | 29 | 28 | |
| Tax % | 25% | 25% | 25% | 24% | 26% | 24% | 23% | 27% | 25% | 24% | 25% | 27% | 26% | |
| Net Profit | 12 | 6 | 9 | 12 | 12 | 15 | 22 | 18 | 19 | 20 | 18 | 21 | 21 | |
| EPS in Rs | 2.63 | 1.34 | 2.14 | 2.79 | 2.77 | 3.44 | 4.84 | 4.12 | 4.24 | 4.47 | 3.94 | 4.73 | 4.71 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202635.66%Promoter
Promoters35.66%0.19
FIIs4.41%0.48
DIIs0.37%0.24
Public59.55%0.43
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Syngene Intl. | ₹369.05 | 50.30 | 14,897 | 0.34% | −9 | −94.89% | 736 | −15.84% | 9.99% |
| Indegene | ₹600.10 | 34.73 | 14,458 | 0.37% | 116 | −0.17% | 1,063 | +39.73% | 18.82% |
| Suven Life Scie. | ₹341.55 | — | 9,651 | 0.00% | −128 | −147.69% | 4 | +90.91% | −79.54% |
| Vimta Labs | ₹603.10 | 33.36 | 2,696 | 0.33% | 21 | +11.38% | 109 | +11.80% | 25.23% |
| Fabtech Tech. | ₹147.93 | 13.52 | 658 | 0.41% | 4 | +154.79% | 75 | +10.25% | 13.58% |
| Bilcare | ₹107.62 | 12.74 | 253 | 0.00% | 15 | +473.06% | 226 | +21.20% | 7.06% |
| Take | ₹15.96 | 40.02 | 236 | 0.00% | 1 | +282.76% | 30 | — | 18.52% |
| Median: 9 Co. | ₹147.93 | 37.38 | 658 | 0.00% | 1 | +117.42% | 75 | +30.46% | 10.87% |
Filings
Annual reports15
Concall transcripts47
TranscriptJul 2026PPTJul 2026RECJul 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptJul 2025PPTJul 2025RECJul 2025PPTJul 2025PPTJul 2025TranscriptMay 2025PPTMay 2025RECMay 2025PPTApr 2025PPTJan 2025TranscriptNov 2024PPTNov 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 16 Sep - Allotment of Employee Stock Options under "Vimta Labs Employee Stock Option Plan 2021".Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8 Sep - Vimta Labs schedules analyst and institutional investor meet on 08.09.2026.Announcement under Regulation 30 (LODR)-Credit Rating 2 Sep - CARE Ratings reaffirmed Vimta Labs’ bank facilities at CARE A; Stable and CARE A1 on 02 September 2026.Clarification Regarding Increase In Volume Of Our Securities Across Exchanges. 1 Sep - Vimta Labs says share volume spike is due to market factors, with no undisclosed information.Clarification sought from Vimta Labs Ltd 1 Sep - Exchange has sought clarification from Vimta Labs Ltd on September 01, 2026, with reference to Movement in Volume.